Upstream Biotechnology Overview
- Year Founded
-
2017
- Status
-
Private
- Employees
-
9
- Latest Deal Type
-
Seed
- Investors
-
12
Upstream Biotechnology General Information
Description
Developer of disease-resistant crops intended to eliminate pesticide use. The company uses ribonucleic acid-based plant trait development, gene expression control, stress-responsive plant technologies, crop trait validation, and research collaboration capabilities to improve crop resilience against environmental stress, enabling agricultural biotechnology organizations and plant breeders to develop resilient crops, improve agricultural productivity, and support sustainable farming practices.
Contact Information
Website
www.upstreambiotech.comCorporate Office
- 701 West Main Street
- Suite 200
- Durham, NC 27701
- United States
Corporate Office
- 701 West Main Street
- Suite 200
- Durham, NC 27701
- United States
Upstream Biotechnology Timeline
Upstream Biotechnology Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 9. Seed Round | 28-Jul-2026 | Completed | Generating Revenue | |||
| 8. Accelerator/Incubator | 01-Jan-2026 | Completed | Generating Revenue | |||
| 7. Seed Round | 03-Sep-2025 | Completed | Generating Revenue | |||
| 6. Accelerator/Incubator | 17-Jan-2024 | Completed | Generating Revenue | |||
| 5. Accelerator/Incubator | 01-Jan-2024 | Completed | Generating Revenue | |||
| 4. Debt - General | 01-Oct-2023 | Completed | Generating Revenue | |||
| 3. Grant | 01-Jan-2022 | Completed | Generating Revenue | |||
| 2. Grant | 01-Feb-2019 | $225K | Completed | Startup | ||
| 1. Accelerator/Incubator | 21-Nov-2017 | Completed | Startup |
Upstream Biotechnology Cap Table
| Stock | # of Shares Authorized |
Par Value | Dividend Rate (%) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price | % Owned |
|---|---|---|---|---|---|---|---|---|
| Seed |
VC Exit Predictor
See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.
Upstream Biotechnology Signals
Upstream Biotechnology Investors (12)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| Corteva | Corporation | Minority | ||
| LeVert Ventures | Venture Capital | Minority | ||
| Redstick Ventures | Venture Capital | Minority | ||
| SilverBlue | Venture Capital | Minority | ||
| Skull Diamond and Heart Capital | Venture Capital | Minority |
Upstream Biotechnology FAQs
-
When was Upstream Biotechnology founded?
Upstream Biotechnology was founded in 2017.
-
Where is Upstream Biotechnology headquartered?
Upstream Biotechnology is headquartered in Durham, NC.
-
What is the size of Upstream Biotechnology?
Upstream Biotechnology has 9 total employees.
-
What industry is Upstream Biotechnology in?
Upstream Biotechnology’s primary industry is Cultivation.
-
Is Upstream Biotechnology a private or public company?
Upstream Biotechnology is a Private company.
-
What is Upstream Biotechnology’s current revenue?
The current revenue for Upstream Biotechnology is .
-
How much funding has Upstream Biotechnology raised over time?
Upstream Biotechnology has raised $825K.
-
Who are Upstream Biotechnology’s investors?
Corteva, LeVert Ventures, Redstick Ventures, SilverBlue, and Skull Diamond and Heart Capital are 5 of 12 investors who have invested in Upstream Biotechnology.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process